Release Date: 31/08/20 09:08 Summary: FY20 Results Release Cover Note Price Sensitive: No Download Document 255.51KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%